{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T14:13:04Z","timestamp":1777299184488,"version":"3.51.4"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["12POST10680000"],"award-info":[{"award-number":["12POST10680000"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["1F32HL124893-01"],"award-info":[{"award-number":["1F32HL124893-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["HL116848"],"award-info":[{"award-number":["HL116848"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["AG043822"],"award-info":[{"award-number":["AG043822"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["HL114887"],"award-info":[{"award-number":["HL114887"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["14510001"],"award-info":[{"award-number":["14510001"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jmmc-online.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.yjmcc.2015.03.010","type":"journal-article","created":{"date-parts":[[2015,3,18]],"date-time":"2015-03-18T16:44:25Z","timestamp":1426697065000},"page":"14-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Non-sirtuin histone deacetylases in the control of cardiac aging"],"prefix":"10.1016","volume":"83","author":[{"given":"Bradley S.","family":"Ferguson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy A.","family":"McKinsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2015.03.010_bb0005","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1126\/science.1175371","article-title":"Lysine acetylation targets protein complexes and co-regulates major cellular functions","volume":"325","author":"Choudhary","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0010","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.celrep.2012.07.006","article-title":"Proteomic analysis of lysine acetylation sites in rat tissues reveals organ specificity and subcellular patterns","volume":"2","author":"Lundby","year":"2012","journal-title":"Cell Rep"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jmb.2004.02.006","article-title":"Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis","volume":"338","author":"Gregoretti","year":"2004","journal-title":"J Mol Biol"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1517\/14740338.7.1.53","article-title":"Histone deacetylase inhibition in the treatment of heart disease","volume":"7","author":"Berry","year":"2008","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0025","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-pharmtox-010611-134712","article-title":"Therapeutic potential for HDAC inhibitors in the heart","volume":"52","author":"McKinsey","year":"2012","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0030","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1073\/pnas.1015081108","article-title":"Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy","volume":"108","author":"Cao","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0035","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCULATIONAHA.105.559724","article-title":"Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding","volume":"113","author":"Kee","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0040","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1161\/CIRCULATIONAHA.113.002416","article-title":"Histone deacetylase inhibition blunts ischemia\/reperfusion injury by inducing cardiomyocyte autophagy","volume":"129","author":"Xie","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0045","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/cvr\/cvr358","article-title":"Autophagy as a therapeutic target for ischaemia\/reperfusion injury? Concepts, controversies, and challenges","volume":"94","author":"Przyklenk","year":"2012","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0050","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.yjmcc.2014.03.005","article-title":"Selective inhibition of class I but not class IIb histone deacetylases exerts cardiac protection from ischemia reperfusion","volume":"72","author":"Aune","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0055","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.yjmcc.2014.02.015","article-title":"Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs","volume":"70","author":"Schuetze","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0060","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.yjmcc.2013.12.013","article-title":"Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes","volume":"67","author":"Williams","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0065","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1755-1536-7-10","article-title":"HDAC class I inhibitor, Mocetinostat, reverses cardiac fibrosis in heart failure and diminishes CD90+ cardiac myofibroblast activation","volume":"7","author":"Nural-Guvener","year":"2014","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0070","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1016\/j.cellsig.2014.09.005","article-title":"Class I HDAC inhibition stimulates cardiac protein SUMOylation through a post-translational mechanism","volume":"26","author":"Blakeslee","year":"2014","journal-title":"Cell Signal"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0075","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1161\/CIRCRESAHA.114.304125","article-title":"Wrestling with heart failure: SUMO-1 to the rescue","volume":"114","author":"Vejpongsa","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0080","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.yjmcc.2014.01.019","article-title":"Epigenetic regulation of fibrocyte differentiation?","volume":"69","author":"Lishnevsky","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0085","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.exphem.2010.03.004","article-title":"Fibrocytes in health and disease","volume":"38","author":"Herzog","year":"2010","journal-title":"Exp Hematol"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0090","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.yjmcc.2010.10.019","article-title":"Immune-inflammatory dysregulation modulates the incidence of progressive fibrosis and diastolic stiffness in the aging heart","volume":"50","author":"Cieslik","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0095","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.gde.2008.10.001","article-title":"Eloquent silence: developmental functions of Class I histone deacetylases","volume":"18","author":"Cunliffe","year":"2008","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0100","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1042\/BST20130010","article-title":"The physiological roles of histone deacetylase (HDAC) 1 and 2: complex co-stars with multiple leading parts","volume":"41","author":"Kelly","year":"2013","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0105","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1038\/sj.onc.1209473","article-title":"Histone deacetylase 3 localizes to the plasma membrane and is a substrate of Src","volume":"25","author":"Longworth","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0110","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1074\/jbc.M110.163865","article-title":"HDAC3-dependent reversible lysine acetylation of cardiac myosin heavy chain isoforms modulates their enzymatic and motor activity","volume":"286","author":"Samant","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0115","article-title":"The role of histone deacetylase 2 and its posttranslational modifications in cardiac hypertrophy","author":"Eom","year":"2014","journal-title":"BMB Rep"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0120","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/CIRCRESAHA.114.303429","article-title":"Regulation of acetylation of histone deacetylase 2 by p300\/CBP-associated factor\/histone deacetylase 5 in the development of cardiac hypertrophy","volume":"114","author":"Eom","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0125","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1172\/JCI35847","article-title":"Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice","volume":"118","author":"Montgomery","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0130","doi-asserted-by":"crossref","first-page":"33301","DOI":"10.1074\/jbc.M111.277707","article-title":"Diet-induced lethality due to deletion of the HDAC3 gene in heart and skeletal muscle","volume":"286","author":"Sun","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0135","doi-asserted-by":"crossref","first-page":"e000670","DOI":"10.1161\/JAHA.113.000670","article-title":"Cardiac CD47 drives left ventricular heart failure through Ca2+-CaMKII-regulated induction of HDAC3","volume":"3","author":"Sharifi-Sanjani","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0140","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.molcel.2013.10.022","article-title":"Deacetylase-independent function of HDAC3 in transcription and metabolism requires nuclear receptor corepressor","volume":"52","author":"Sun","year":"2013","journal-title":"Mol Cell"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0145","doi-asserted-by":"crossref","first-page":"9806","DOI":"10.1073\/pnas.1301509110","article-title":"Signal-dependent repression of DUSP5 by class I HDACs controls nuclear ERK activity and cardiomyocyte hypertrophy","volume":"110","author":"Ferguson","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0150","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nm.1893","article-title":"A new type of ERK1\/2 autophosphorylation causes cardiac hypertrophy","volume":"15","author":"Lorenz","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0155","doi-asserted-by":"crossref","first-page":"7440","DOI":"10.1073\/pnas.1221999110","article-title":"Interference with ERK(Thr188) phosphorylation impairs pathological but not physiological cardiac hypertrophy","volume":"110","author":"Ruppert","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0160","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1128\/MCB.01205-10","article-title":"Acetylation of a conserved lysine residue in the ATP binding pocket of p38 augments its kinase activity during hypertrophy of cardiomyocytes","volume":"31","author":"Pillai","year":"2011","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0165","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.cardiores.2007.08.010","article-title":"Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury","volume":"76","author":"Zhao","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0170","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000350148","article-title":"HDAC inhibition suppresses cardiac hypertrophy and fibrosis in DOCA-salt hypertensive rats via regulation of HDAC6\/HDAC8 enzyme activity","volume":"37","author":"Kee","year":"2013","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0175","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1021\/cb500492r","article-title":"An unbiased approach to identify endogenous substrates of \u201chistone\u201d deacetylase 8","volume":"9","author":"Olson","year":"2014","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0180","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/bip.22135","article-title":"HDAC8 substrates: histones and beyond","volume":"99","author":"Wolfson","year":"2013","journal-title":"Biopolymers"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0185","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1096\/fj.04-2303fje","article-title":"Histone deacetylase HDAC8 associates with smooth muscle alpha-actin and is essential for smooth muscle cell contractility","volume":"19","author":"Waltregny","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0190","doi-asserted-by":"crossref","first-page":"34346","DOI":"10.1074\/jbc.M111.278549","article-title":"Acetylation of heat shock protein 20 (Hsp20) regulates human myometrial activity","volume":"286","author":"Karolczak-Bayatti","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0195","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1074\/jbc.M114.618454","article-title":"Specific inhibition of histone deacetylase 8 reduces gene expression and production of proinflammatory cytokines in vitro and in vivo","volume":"290","author":"Li","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0200","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.cardiores.2006.11.036","article-title":"Derepression of pathological cardiac genes by members of the CaM kinase superfamily","volume":"73","author":"McKinsey","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0205","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.bmcl.2008.02.025","article-title":"Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases","volume":"18","author":"Jones","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0210","doi-asserted-by":"crossref","first-page":"17335","DOI":"10.1073\/pnas.0706487104","article-title":"Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases","volume":"104","author":"Lahm","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0215","doi-asserted-by":"crossref","first-page":"7302","DOI":"10.1128\/MCB.22.20.7302-7312.2002","article-title":"Association of class II histone deacetylases with heterochromatin protein 1: potential role for histone methylation in control of muscle differentiation","volume":"22","author":"Zhang","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0220","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1172\/JCI61084","article-title":"HDAC4 controls histone methylation in response to elevated cardiac load","volume":"123","author":"Hohl","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0225","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.tcb.2008.04.003","article-title":"HDAC6: a key regulator of cytoskeleton, cell migration and cell\u2013cell interactions","volume":"18","author":"Valenzuela-Fernandez","year":"2008","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0230","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/CIRCULATIONAHA.113.005300","article-title":"Activation of histone deacetylase-6 induces contractile dysfunction through derailment of alpha-tubulin proteostasis in experimental and human atrial fibrillation","volume":"129","author":"Zhang","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0235","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.yjmcc.2011.04.005","article-title":"Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension","volume":"51","author":"Lemon","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0240","doi-asserted-by":"crossref","first-page":"10842","DOI":"10.1021\/ja102758v","article-title":"Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A","volume":"132","author":"Butler","year":"2010","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0245","doi-asserted-by":"crossref","first-page":"H252","DOI":"10.1152\/ajpheart.00149.2014","article-title":"HDAC6 contributes to pathological responses of heart and skeletal muscle to chronic angiotensin-II signaling","volume":"307","author":"Demos-Davies","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0250","doi-asserted-by":"crossref","first-page":"E5178","DOI":"10.1073\/pnas.1415589111","article-title":"Tubulin hyperacetylation is adaptive in cardiac proteotoxicity by promoting autophagy","volume":"111","author":"McLendon","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0255","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10741-010-9166-6","article-title":"Role of autophagy in heart failure associated with aging","volume":"15","author":"De Meyer","year":"2010","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0260","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nchembio.313","article-title":"Chemical phylogenetics of histone deacetylases","volume":"6","author":"Bradner","year":"2010","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0265","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1161\/CIRCRESAHA.115.302922","article-title":"Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies","volume":"115","author":"Sharma","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0270","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/eurheartj\/ehq426","article-title":"Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment","volume":"32","author":"Borlaug","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0275","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/HCO.0b013e32834b7faf","article-title":"Why are women more likely than men to develop heart failure with preserved ejection fraction?","volume":"26","author":"Scantlebury","year":"2011","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0280","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1056\/NEJMoa051530","article-title":"Outcome of heart failure with preserved ejection fraction in a population-based study","volume":"355","author":"Bhatia","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0285","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0290","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0295","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1001\/jama.300.4.431","article-title":"Heart failure with preserved ejection fraction: treat now by treating comorbidities","volume":"300","author":"Shah","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0300","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.tcm.2009.12.004","article-title":"Cardiac aging in mice and humans: the role of mitochondrial oxidative stress","volume":"19","author":"Dai","year":"2009","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0305","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","article-title":"Inflamm-aging. An evolutionary perspective on immunosenescence","volume":"908","author":"Franceschi","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0310","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1096\/fj.04-2622fje","article-title":"Age-associated increases in oxidative stress and antioxidant enzyme activities in cardiac interfibrillar mitochondria: implications for the mitochondrial theory of aging","volume":"19","author":"Judge","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0315","doi-asserted-by":"crossref","first-page":"615312","DOI":"10.1155\/2014\/615312","article-title":"The role of oxidative stress and inflammation in cardiovascular aging","volume":"2014","author":"Wu","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0320","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2119\/molmed.2011.00022","article-title":"Targeting inflammation in heart failure with histone deacetylase inhibitors","volume":"17","author":"McKinsey","year":"2011","journal-title":"Mol Med"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0325","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/HYPERTENSIONAHA.110.154567","article-title":"HDAC inhibition attenuates inflammatory, hypertrophic, and hypertensive responses in spontaneously hypertensive rats","volume":"56","author":"Cardinale","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0330","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1021\/ml1001954","article-title":"Effect of inhibiting histone deacetylase with short-chain carboxylic acids and their hydroxamic acid analogs on vertebrate development and neuronal chromatin","volume":"2","author":"Fass","year":"2010","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0335","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.yjmcc.2010.01.006","article-title":"Involvement of NADPH oxidase in age-associated cardiac remodeling","volume":"48","author":"Wang","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0340","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.exger.2013.06.002","article-title":"Age-dependent mitochondrial energy dynamics in the mice heart: role of superoxide dismutase-2","volume":"48","author":"Das","year":"2013","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0345","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1161\/CIRCULATIONAHA.108.822403","article-title":"Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging","volume":"119","author":"Dai","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0350","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/gerona\/63.8.813","article-title":"Reduction of age-associated pathology in old mice by overexpression of catalase in mitochondria","volume":"63","author":"Treuting","year":"2008","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0355","doi-asserted-by":"crossref","first-page":"9633","DOI":"10.1073\/pnas.0803749105","article-title":"HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation","volume":"105","author":"Parmigiani","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0360","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1038\/ncomms4479","article-title":"Microtubule acetylation amplifies p38 kinase signalling and anti-inflammatory IL-10 production","volume":"5","author":"Wang","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0365","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1128\/MCB.05155-11","article-title":"Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3(+) T-regulatory cells","volume":"31","author":"de Zoeten","year":"2011","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0370","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1161\/CIRCRESAHA.109.209338","article-title":"Protein acetylation in the cardiorenal axis: the promise of histone deacetylase inhibitors","volume":"106","author":"Bush","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0375","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/CIRCRESAHA.115.302929","article-title":"Heart failure with preserved ejection fraction: molecular pathways of the aging myocardium","volume":"115","author":"Loffredo","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0380","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.yjmcc.2010.11.009","article-title":"Isoform-selective HDAC inhibitors: closing in on translational medicine for the heart","volume":"51","author":"McKinsey","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0385","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1091\/mbc.E13-08-0444","article-title":"Estrogen regulates histone deacetylases to prevent cardiac hypertrophy","volume":"24","author":"Pedram","year":"2013","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0390","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1517\/17425255.2013.754011","article-title":"Toxicological and metabolic considerations for histone deacetylase inhibitors","volume":"9","author":"Fraczek","year":"2013","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0395","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/FJC.0000000000000007","article-title":"Cardiac titin and heart disease","volume":"63","author":"LeWinter","year":"2014","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.yjmcc.2015.03.010_bb0400","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10741-010-9167-5","article-title":"Modulation of sarcoplasmic reticulum Ca(2+) cycling in systolic and diastolic heart failure associated with aging","volume":"15","author":"Janczewski","year":"2010","journal-title":"Heart Fail Rev"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282815000887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282815000887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T03:36:24Z","timestamp":1566444984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282815000887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":80,"alternative-id":["S0022282815000887"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2015.03.010","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-sirtuin histone deacetylases in the control of cardiac aging","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2015.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}